Table 1 Demographic and clinical characteristics of participants
Variable | vNOTES group (n = 92) | LH group (n = 238) | Test value | P |
|---|---|---|---|---|
Age (years) | 50.4 ± 8.0 | 51.3 ± 6.9 | -1.066 | 0.287 |
BMI (kg/m2) | 24.8 ± 4.6 | 25.0 ± 4.1 | -0.429 | 0.668 |
ASA | Â | Â | 6.792 | 0.079 |
 I, n (%) | 2(2.2) | 5(2.1) |  |  |
 II, n (%) | 80(87.0) | 187(78.6) |  |  |
 III, n (%) | 9(9.8) | 46(19.3) |  |  |
 IV, n (%) | 1(1.0) | 0 |  |  |
Parity | 2(1～2) | 2(1～2) | -0.509 | 0.542 |
Type of occupation | Â | Â | 0.279 | 0.597 |
 Physical labor, n (%) | 185(77.7) | 23(75.0) |  |  |
 Intellectual work, n (%) | 53(22.3) | 68(25.0) |  |  |
Previous abdominal surgery | Â | Â | 1.449 | 0.229 |
 Yes, n (%) | 35(38.0) | 74(31.1) |  |  |
 NO, n (%) | 57(62.0) | 164(68.9) |  |  |
Histological subtype | Â | Â | 2.452 | 0.784 |
 CIN II, n (%) | 12(13.0) | 31(13.0) |  |  |
 CIN III, n (%) | 38(41.3) | 104(43.7) |  |  |
 CIN II+Uterine fibroid, n (%) | 13(14.1) | 36(15.1) |  |  |
 CIN III+Uterine fibroid, n (%) | 23(25.0) | 44(18.5) |  |  |
 CIN III+adenomyosis, n (%) | 5(5.4) | 17(7.2) |  |  |
 Other begin disease, n (%) | 1(1.1) | 6(2.5) |  |  |
Uterus volume (cm3) | 136.5(70.9～257.1) | 151.4(59.2～295.5) | -0.635 | 0.525 |
Follow-up period | 15 (5～15) | 15 (9～15) | -1.187 | 0.235 |
Follow-up period | Â | Â | 0.011 | 0.915 |
 < 3 months | 12 (13.0) | 30 (13.6) |  |  |
 ≥ 3 months | 80 (87.0) | 208 (87.4) |  |  |